Ángela Martín

623 total citations
15 papers, 521 citations indexed

About

Ángela Martín is a scholar working on Molecular Biology, Physiology and Nutrition and Dietetics. According to data from OpenAlex, Ángela Martín has authored 15 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Physiology and 5 papers in Nutrition and Dietetics. Recurrent topics in Ángela Martín's work include Nitric Oxide and Endothelin Effects (6 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Ángela Martín is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Ángela Martín collaborates with scholars based in Spain, Brazil and United Kingdom. Ángela Martín's co-authors include María J. Alonso, Mercedes Salaíces, Raquel Hernanz, Roberto Palacios, Andrea Aguado, Ana M. Briones, Priscila Rossi de Batista, Dalton Valentim Vassallo, Victoria Cachofeiro and José Vicente Pérez-Girón and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Ángela Martín

15 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ángela Martín Spain 11 137 114 114 108 80 15 521
Nathawut Sibmooh Thailand 15 137 1.0× 194 1.7× 69 0.6× 46 0.4× 84 1.1× 41 690
Andrea Aguado Spain 13 284 2.1× 176 1.5× 154 1.4× 177 1.6× 123 1.5× 17 876
Kristien Daenen Belgium 5 240 1.8× 77 0.7× 86 0.8× 38 0.4× 50 0.6× 5 710
Margarita Díaz-Flores Mexico 18 248 1.8× 131 1.1× 69 0.6× 103 1.0× 32 0.4× 37 754
Pilar Martı́n-Gallán Spain 11 161 1.2× 135 1.2× 84 0.7× 189 1.8× 23 0.3× 12 1.2k
Rafael Medina-Navarro Mexico 16 165 1.2× 153 1.3× 56 0.5× 42 0.4× 43 0.5× 32 662
Aymelek Gönenç Türkiye 12 239 1.7× 60 0.5× 104 0.9× 28 0.3× 37 0.5× 23 672
Eulises Díaz‐Díaz Mexico 17 214 1.6× 198 1.7× 75 0.7× 39 0.4× 25 0.3× 41 734
Т. П. Новгородцева Russia 11 105 0.8× 180 1.6× 134 1.2× 37 0.3× 18 0.2× 89 497
Stefanie Deubel Germany 15 398 2.9× 79 0.7× 266 2.3× 62 0.6× 70 0.9× 24 770

Countries citing papers authored by Ángela Martín

Since Specialization
Citations

This map shows the geographic impact of Ángela Martín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ángela Martín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ángela Martín more than expected).

Fields of papers citing papers by Ángela Martín

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ángela Martín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ángela Martín. The network helps show where Ángela Martín may publish in the future.

Co-authorship network of co-authors of Ángela Martín

This figure shows the co-authorship network connecting the top 25 collaborators of Ángela Martín. A scholar is included among the top collaborators of Ángela Martín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ángela Martín. Ángela Martín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Finks, Shannon W., et al.. (2025). Real‐world observations of using compounded GLP ‐1 ±  GIP agonists within a clinical pharmacist‐managed cardiometabolic clinic. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 8(2). 91–97. 1 indexed citations
2.
Hernanz, Raquel, et al.. (2023). Regulation by Nrf2 of IL-1β-induced inflammatory and oxidative response in VSMC and its relationship with TLR4. Frontiers in Pharmacology. 14. 15 indexed citations
3.
Hernanz, Raquel, Ángela Martín, Ana M. Briones, et al.. (2023). The Melatonin Derivative ITH13001 Prevents Hypertension and Cardiovascular Alterations in Angiotensin II-Infused Mice. Journal of Pharmacology and Experimental Therapeutics. 388(2). 670–687. 4 indexed citations
4.
Martinez, Caroline Silveira, Ángela Martín, Roberto Palacios, et al.. (2019). Egg White Hydrolysate: A new putative agent to prevent vascular dysfunction in rats following long-term exposure to aluminum. Food and Chemical Toxicology. 133. 110799–110799. 17 indexed citations
5.
Palacios, Roberto, Raquel Hernanz, Ángela Martín, et al.. (2019). Pioglitazone Modulates the Vascular Contractility in Hypertension by Interference with ET-1 Pathway. Scientific Reports. 9(1). 16461–16461. 23 indexed citations
6.
Garcés‐Rimón, Marta, Cristina González, Raquel Hernanz, et al.. (2019). Egg white hydrolysates improve vascular damage in obese Zucker rats by its antioxidant properties. Journal of Food Biochemistry. 43(12). e13062–e13062. 7 indexed citations
7.
Martín, Ángela, Patricia Corrales, Maylla Ronacher Simões, et al.. (2017). Egg white-derived peptides prevent cardiovascular disorders induced by mercury in rats: Role of angiotensin-converting enzyme (ACE) and NADPH oxidase. Toxicology Letters. 281. 158–174. 34 indexed citations
8.
Martinez, Caroline Silveira, Ángela Martín, Roberto Palacios, et al.. (2017). Aluminum exposure at human dietary levels promotes vascular dysfunction and increases blood pressure in rats: A concerted action of NAD(P)H oxidase and COX-2. Toxicology. 390. 10–21. 41 indexed citations
9.
Hernanz, Raquel, Sonia Martínez‐Revelles, Roberto Palacios, et al.. (2015). Toll‐like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II‐induced hypertension. British Journal of Pharmacology. 172(12). 3159–3176. 125 indexed citations
10.
Pérez-Girón, José Vicente, Roberto Palacios, Ángela Martín, et al.. (2014). Pioglitazone reduces angiotensin II-induced COX-2 expression through inhibition of ROS production and ET-1 transcription in vascular cells from spontaneously hypertensive rats. American Journal of Physiology-Heart and Circulatory Physiology. 306(11). H1582–H1593. 23 indexed citations
11.
Batista, Priscila Rossi de, Roberto Palacios, Ángela Martín, et al.. (2014). Toll-Like Receptor 4 Upregulation by Angiotensin II Contributes to Hypertension and Vascular Dysfunction through Reactive Oxygen Species Production. PLoS ONE. 9(8). e104020–e104020. 101 indexed citations
12.
Aguado, Andrea, María Galán, Olha Zhenyukh, et al.. (2013). Mercury induces proliferation and reduces cell size in vascular smooth muscle cells through MAPK, oxidative stress and cyclooxygenase-2 pathways. Toxicology and Applied Pharmacology. 268(2). 188–200. 46 indexed citations
13.
Hernanz, Raquel, Ángela Martín, José Vicente Pérez-Girón, et al.. (2012). Pioglitazone treatment increases COX‐2‐derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function. British Journal of Pharmacology. 166(4). 1303–1319. 24 indexed citations
14.
Martín, Ángela, José Vicente Pérez-Girón, Raquel Hernanz, et al.. (2011). Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress. Journal of Hypertension. 30(2). 315–326. 50 indexed citations
15.
Hernanz, Raquel, Ana M. Briones, Ángela Martín, et al.. (2008). Ouabain treatment increases nitric oxide bioavailability and decreases superoxide anion production in cerebral vessels. Journal of Hypertension. 26(10). 1944–1954. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathawut Sibmooh Breakdown of academic impact, for papers by Andrea Aguado Breakdown of academic impact, for papers by Kristien Daenen Breakdown of academic impact, for papers by Margarita Díaz-Flores Breakdown of academic impact, for papers by Pilar Martı́n-Gallán Breakdown of academic impact, for papers by Rafael Medina-Navarro Breakdown of academic impact, for papers by Aymelek Gönenç Breakdown of academic impact, for papers by Eulises Díaz‐Díaz Breakdown of academic impact, for papers by Т. П. Новгородцева Breakdown of academic impact, for papers by Stefanie Deubel
Rankless by CCL
2026